Contineum Therapeutics, Inc. Class A Common Stock Net Asset Momentum
Contineum Therapeutics, Inc. Class A Common Stock net asset momentum. Contineum Therapeutics, Inc. Class A Common Stock (CTNM) recorded a net asset momentum of 31.8% as of December 2025, with net assets of $260.99 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Contineum Therapeutics, Inc. Class A Com capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Contineum Therapeutics, Inc. Class A Common Stock (2021–2025)
Net asset momentum of Contineum Therapeutics, Inc. Class A Common Stock from 2021 to 2025. This chart tracks Contineum Therapeutics, Inc. Class A Common Stock's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +31.8%, with net assets of $260.99 Million USD as of December 2025. See shareholders equity of Contineum Therapeutics, Inc. Class A Com for net asset value and shareholders' equity analysis.
Contineum Therapeutics, Inc. Class A Common Stock Net Asset Momentum by Year (2021–2025)
Contineum Therapeutics, Inc. Class A Common Stock net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for Contineum Therapeutics, Inc. Class A Common Stock from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Contineum Therapeutics, Inc. Class A Com market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $260.99 Million | $276.64 Million | $15.65 Million | ▲ +31.8% |
| 2024 | $198.07 Million | $212.85 Million | $14.78 Million | ▲ +391.5% |
| 2023 | $-67.94 Million | $130.39 Million | $198.32 Million | ▼ -273.0% |
| 2022 | $39.27 Million | $50.64 Million | $11.37 Million | ▼ -36.2% |
| 2021 | $61.59 Million | $70.52 Million | $8.93 Million | — |